Search research articles
Contact Us
Filters
Showing results (511-520 of 548) with videos related to
Page
of 55
Sort By:
The American Journal of Cardiology
|
October 8, 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries
J M Miller, R Smalling, E M Ohman, et al.
Annals of Emergency Medicine
|
December 2, 1998
Prospective use of glycoprotein IIb/IIIa receptor blockers in the emergency department setting
W B Gibler, R G Wilcox, C Bode, et al.
The Journal of International Medical Research
|
November 26, 2019
Influence of extracorporeal membrane oxygenation on serum microRNA expression
M Scettri, H Seeba, D L Staudacher, et al.
Journal of Medicinal Chemistry
|
December 25, 1992
Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones
B Singh, G Y Lesher, K C Pluncket, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1991
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo
M S Runge, T Quertermous, P J Zavodny, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 5, 2013
Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition
F Guenther, N Herr, M Mauler, et al.
Hamostaseologie
|
November 2, 2012
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]
M Spannagl, R Bauersachs, E S Debus, et al.
Biomaterials
|
April 20, 2015
Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis
S Meier, G Pütz, U Massing, et al.
Circulation
|
September 1, 1996
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators
C Bode, R W Smalling, G Berg, et al.
American Heart Journal
|
August 30, 2003
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II)
P W Armstrong, J Burton, S Pakola, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 548) with videos related to
Sort By:
Page
of 55
The American Journal of Cardiology
|
October 8, 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries
J M Miller, R Smalling, E M Ohman, et al.
Annals of Emergency Medicine
|
December 2, 1998
Prospective use of glycoprotein IIb/IIIa receptor blockers in the emergency department setting
W B Gibler, R G Wilcox, C Bode, et al.
The Journal of International Medical Research
|
November 26, 2019
Influence of extracorporeal membrane oxygenation on serum microRNA expression
M Scettri, H Seeba, D L Staudacher, et al.
Journal of Medicinal Chemistry
|
December 25, 1992
Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones
B Singh, G Y Lesher, K C Pluncket, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1991
A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo
M S Runge, T Quertermous, P J Zavodny, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 5, 2013
Contrast ultrasound for the quantification of deep vein thrombosis in living mice: effects of enoxaparin and P2Y12 receptor inhibition
F Guenther, N Herr, M Mauler, et al.
Hamostaseologie
|
November 2, 2012
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]
M Spannagl, R Bauersachs, E S Debus, et al.
Biomaterials
|
April 20, 2015
Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis
S Meier, G Pütz, U Massing, et al.
Circulation
|
September 1, 1996
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators
C Bode, R W Smalling, G Berg, et al.
American Heart Journal
|
August 30, 2003
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II)
P W Armstrong, J Burton, S Pakola, et al.
Page
of 55